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Introduction
To describe two distinct desensitisation protocols for
colistin successfully used in the same patient in two dif-
ferent instances.
Case summary
A 42-year old male suffering from chronic osteomyelytis
of the left femoral bone due to Pseudomonas aerugi-
nosa, was treated with intravenous colistin for 24 days.
During this treatment he developed 3 mild reactions
with rash and pruritus treated with anti-histamines.
Eight months later he was readmitted in the hospital
due to a relapse.Colistin was administered again as the
pathogen was resistant to all other antibiotics. During
the first intravenous infusion of colistin he developed
severe anaphylaxis with generalised pruritus and
erythema, low blood pressure, dyspnea, vommitting,
diarrhea and feeling of imminent death. Skin prick and
intradermal tests with the culprit drug were positive. A
rush desensitisation protocol adapted from Tosi et al
was implemented with only mild adverse reactions until
therapeutic dose was reached. The patient tolerated
colistin for 3 weeks. The drug was discontinued as new
cultivations had to be obtained and was readministered
8 days later. Prior to the continuation of treatment new
tests were performed with the SPT being negative this
time, although intradermal tests were positive at the
same dilution. Thus, a new faster and shorter protocol
was developed and succefully tolerated by the patient
without any reactions.
Discussion
Increased incidence of serious infections caused by
gram-negative bacteria led to greater use of colistin.
Anaphylaxis to this antibiotic has rarely been reported.
To the best of our knowledge this is the first case, in
which an IgE mediated mechanism has been proven. We
also demonstrate that tolerance after discontinuation of
colistin, achieved by a desensitisation procedure, may last
longer than it is generally believed for antibiotics.
Conclusion
Colistin desensitisation can be a viable option for
patients with serious gram-negative infections when no
alternative drug is available.
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